AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 84 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,599,283 | -36.7% | 1,902,843 | +1.3% | 0.23% | -37.3% |
| Q2 2023 | $30,971,573 | +79.9% | 1,879,343 | 0.0% | 0.37% | +56.8% |
| Q1 2023 | $17,214,782 | +292.1% | 1,879,343 | +206.5% | 0.23% | +296.6% |
| Q4 2022 | $4,390,090 | +805.2% | 613,141 | +532.7% | 0.06% | +742.9% |
| Q3 2022 | $485,000 | -87.5% | 96,906 | -93.9% | 0.01% | -88.3% |
| Q2 2022 | $3,868,000 | -73.2% | 1,585,292 | -25.1% | 0.06% | -74.5% |
| Q1 2022 | $14,452,000 | -21.0% | 2,116,029 | -6.5% | 0.24% | -10.3% |
| Q4 2021 | $18,285,000 | +8.0% | 2,263,002 | +31.0% | 0.26% | -5.1% |
| Q3 2021 | $16,925,000 | +981.5% | 1,727,060 | +642.7% | 0.28% | +851.7% |
| Q2 2021 | $1,565,000 | – | 232,537 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,498,838 | $22,889,355 | 11.72% |
| Knoll Capital Management, LLC | 500,000 | $4,580,000 | 7.06% |
| GENDELL JEFFREY L | 5,301,914 | $48,565,532 | 4.55% |
| COWEN AND COMPANY, LLC | 3,732,778 | $34,192,246 | 4.02% |
| Tri Locum Partners LP | 1,327,097 | $12,156,209 | 3.70% |
| Samsara BioCapital, LLC | 1,409,409 | $12,910,186 | 2.67% |
| Altium Capital Management LP | 500,000 | $4,580,000 | 2.54% |
| Vivo Capital, LLC | 3,761,438 | $34,454,772 | 2.39% |
| RTW INVESTMENTS, LP | 5,741,939 | $52,596,161 | 1.10% |
| Knott David M Jr | 291,113 | $2,667 | 1.05% |